News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Multidrug-Resistant Gram-Negative Bacteria and Novel Treatment Approaches

EP. 1: Initial Therapy for MDR Bacteria and Antibiotic Resistance

June 11th 2018

EP. 2: Resistance Issues and Resistance Factors With MDR Bacteria

June 11th 2018

EP. 3: Current Treatments for MDR Bacteria and Their Drawbacks

June 11th 2018

EP. 4: New or Upcoming Treatment Options for MDR Bacteria

June 11th 2018

EP. 5: Future Direction and Advice for Treating MDR Bacteria

June 11th 2018

EP. 6: Risk and Mechanism of MDR Bacterial Infection

June 11th 2018

EP. 7: Gaps and Drawbacks of Current MDR Bacterial Therapy

June 11th 2018

EP. 8: Appropriate Initial Therapy and Mechanism of MDR Bacteria

June 11th 2018

EP. 9: Reviewing the Newly Approved Agents for MDR Bacteria

June 11th 2018

EP. 10: New Diagnostics and Final Message to Treating MDR Bacteria

June 11th 2018

EP. 11: Newly and Emerging Treatment Options for MDR Bacteria

June 11th 2018

EP. 12: Future Direction and Advice for Managing MDR Bacteria

June 11th 2018
Advertisement
Advertisement

Trending on Contagion Live

1

Cefiderocol is Noninferior, But not "Game-Changer," for Gram-negative Bloodstream Infections

2

As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link

3

Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance

4

Misdiagnosis Common in Skin Infections Due to Overlapping Noninfectious Conditions

5

Emerging Diagnostic Tools and Mycobacterial Challenges in Skin and Soft Tissue Infections

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us